Home
About
Overview
Sharing Data
ORCID
Help
History (1)
SENTINEL1: Two-Season Study of Respiratory Syncytial Virus Hospitalizations among U.S. Infants Born at 29 to 35 Weeks' Gestational Age Not Receiving Immunoprophylaxis.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
SENTINEL1: Two-Season Study of Respiratory Syncytial Virus Hospitalizations among U.S. Infants Born at 29 to 35 Weeks' Gestational Age Not Receiving Immunoprophylaxis.
SENTINEL1: Two-Season Study of Respiratory Syncytial Virus Hospitalizations among U.S. Infants Born at 29 to 35 Weeks' Gestational Age Not Receiving Immunoprophylaxis. Am J Perinatol. 2020 03; 37(4):421-429.
View in:
PubMed
subject areas
Antiviral Agents
Antiviral Agents
Community-Acquired Infections
Community-Acquired Infections
Female
Female
Hospitalization
Hospitalization
Humans
Humans
Infant
Infant
Infant, Newborn
Infant, Newborn
Infant, Premature
Infant, Premature
Infant, Premature, Diseases
Infant, Premature, Diseases
Intensive Care Units, Pediatric
Intensive Care Units, Pediatric
Male
Male
Multivariate Analysis
Multivariate Analysis
Odds Ratio
Odds Ratio
Palivizumab
Palivizumab
Respiration, Artificial
Respiration, Artificial
Respiratory Syncytial Virus Infections
Respiratory Syncytial Virus Infections
Respiratory Syncytial Virus, Human
Respiratory Syncytial Virus, Human
United States
United States